Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies

Der Schmerz
F PetzkeWinfried Häuser

Abstract

Recently published systematic reviews came to different conclusions with respect to the efficacy, tolerability and safety of cannabinoids for treatment of chronic neuropathic pain. A systematic search of the literature was carried out in MEDLINE, the Cochrane central register of controlled trials (CENTRAL) and clinicaltrials.gov up until November 2015. We included double-blind randomized placebo-controlled studies (RCT) of at least 2 weeks duration and with at least 9 patients per treatment arm comparing medicinal cannabis, plant-based or synthetic cannabinoids with placebo or any other active drug treatment in patients with chronic neuropathic pain. Clinical endpoints of the analyses were efficacy (more than 30 % or 50 % reduction of pain, average pain intensity, global improvement and health-related quality of life), tolerability (drop-out rate due to side effects, central nervous system and psychiatric side effects) and safety (severe side effects). Using a random effects model absolute risk differences (RD) were calculated for categorical data and standardized mean differences (SMD) for continuous variables. The methodological quality of RCTs was rated by the Cochrane risk of bias tool. We included 15 RCTs with 1619 partici...Continue Reading

References

Apr 7, 2004·Der Orthopäde·R Baron, A Binder
Dec 17, 2004·International Clinical Psychopharmacology·Toshi A FurukawaNorio Watanabe
Nov 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·J P ZajicekA J Thompson
Dec 7, 2007·The Journal of Pain : Official Journal of the American Pain Society·Robert H DworkinStojan Zavisic
Jul 16, 2010·Pain·R Andrew MooreUNKNOWN Cochrane Pain, Palliative and Supportive Care Systematic Review Group Editors
Mar 24, 2011·British Journal of Clinical Pharmacology·Mary E Lynch, Fiona Campbell
Jul 19, 2011·Pain·Troels S JensenRolf-Detlef Treede
Jan 23, 2013·European Journal of Pain : EJP·N B FinnerupR-D Treede
Jun 1, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Peter M Fayers, Ron D Hays
Dec 6, 2014·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·Dwight MoulinUNKNOWN Canadian Pain Society
Jan 13, 2015·Lancet Neurology·Nanna B FinnerupMark Wallace
Jan 31, 2015·Journal of Oral & Facial Pain and Headache·Darrell G BoychukMaria F Orellana
Feb 12, 2015·Clinical Pharmacology and Therapeutics·S M HelfertR Baron
Jun 24, 2015·JAMA : the Journal of the American Medical Association·Penny F WhitingJos Kleijnen
Sep 13, 2015·The Journal of Pain : Official Journal of the American Pain Society·Michael H AndreaeHenry S Sacks

❮ Previous
Next ❯

Citations

Jan 27, 2016·Der Schmerz·L Radbruch, M Schäfer
Feb 6, 2018·Journal of Cachexia, Sarcopenia and Muscle·Martin MückeRupert Conrad
Mar 8, 2018·The Cochrane Database of Systematic Reviews·Martin MückeWinfried Häuser
Jun 18, 2017·Medwave·Rubén F Allende-Salazar, Gabriel Rada
Feb 2, 2017·European Journal of Pain : EJP·N KumowskiE Enax-Krumova
Sep 22, 2019·Der Schmerz·Frank PetzkeUNKNOWN Ad-hoc-Kommission der Deutschen Schmerzgesellschaft „Cannabis in der Medizin“
Dec 25, 2019·Cannabis and Cannabinoid Research·Leonie M MilosevKirsten R Müller-Vahl
Jul 30, 2019·Current Opinion in Anaesthesiology·Haggai Sharon, Silviu Brill
Jun 13, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Andreas KieferHolger Reimann
Sep 25, 2017·Der Schmerz·G LandmannA Ljutow
Jun 9, 2018·Der Schmerz·M Karst
Jan 13, 2019·European Archives of Psychiatry and Clinical Neuroscience·Gabrielle CampbellSuzanne Nielsen
Jun 20, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Eva HochUNKNOWN CaPRis-Projektgruppe
Feb 6, 2020·BMC Complementary Medicine and Therapies·Nadia Montero-OleasDaniel Simancas-Racines
Jun 9, 2020·Current Pain and Headache Reports·John WolfOmar Viswanath
May 30, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Winfried Häuser, Frank Petzke
Oct 12, 2017·Deutsches Ärzteblatt International·Winfried HäuserFrank Petzke
Feb 10, 2021·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Igor DykukhaMichael A Überall
May 6, 2021·MMW Fortschritte der Medizin·Thomas Cegla
Jul 2, 2021·Der Anaesthesist·Michael Schäfer, Sascha Tafelski
Sep 2, 2021·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Markus KöstenbergerRudolf Likar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.